Background: Interstitial lung disease (ILD) is associated with a higher lung cancer (LC) risk and may impact cancer's clinical characteristics, treatment strategies, and outcomes. This impact's extent is unclear, particularly in Caucasians.
Methods: In this retrospective observational study, we reviewed the files of all LC patients diagnosed in a 38-month period.